Construction of transgenic mouse model for gastric cancer by Oshima Hiroko et al.
―  ― 71
Construction of transgenic mouse model for gastric cancer 
 
H. Oshima, T. Fujimura*, M.M. Taketo+ and M. Oshima 
(*Gastroenterologic Surgery, Kanazawa University Hospital, +Department of 
Pharmacology, Kyoto University Graduate School of Medicine) 
 
 It has been demonstrated that nuclear translocation of β-catenin, a hallmark of Wnt 
activation, is found in human gastric cancer, suggesting the causal role of Wnt pathway in 
gastric carcinogenesis. We examined 80 cases of gastric cancer by immunohistochemistry, and 
found nuclear β-catenin in 54% (51% and 58% for intestinal- and diffuse types, respectively).  
Accordingly, it is conceivable that Wnt pathway activation is one of the major causes of gastric 
cancer development regardless of the histological type.  To investigate the genetic mechanism 
further, we constructed transgenic mice (K19-Wnt1) expressing Wnt1, one of the ligands that 
activate the canonical Wnt signaling, in the gastric epithelial cells.  Importantly, trefoil factor 2 
(TFF2)-expressing cell population was expanded in the gastric gland of the K19-Wnt1 mice.  
TFF2 is a marker for undifferentiated gastric epithelium which expresses in the small isthmal 
cells where β-catenin accumulated.  Moreover, we found dysplastic preneoplastic lesions 
consisted of β-catenin-accumulated epithelial cells in the K19-Wnt1 mice (Figure).  These 
results, taken together, suggest that Wnt signaling keeps gastric stem cells and progenitors 
undifferentiated and that activation of Wnt pathway leads to development of preneoplastic 
lesions in the stomach.  For gastric cancer development, activation of an additional pathway 
(e.g., COX-2) appears to be required.  It is of important to investigate compound mutants of 
K19-Wnt1 and K19-C2mE. 
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